NIT
ALNY icon

NumerixS Investment Technologies’s Alnylam Pharmaceuticals ALNY Stock Holding History

NumerixS Investment Technologies’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-800
Closed -$64K – 1032
2019
Q3 		$64K Buy
+800
New +$63.3K 0.02% 668
2018
Q4 		– Sell
-13,791
Closed -$1.24M – 1060
2018
Q3 		$1.24M Buy
13,791
+9,691
+236% +$975K 0.23% 111
2018
Q2 		$398K Buy
+4,100
New +$407K 0.09% 313
2017
Q4 		– Sell
-2,400
Closed -$282K – 1112
2017
Q3 		$282K Buy
+2,400
New +$205K 0.06% 399
2017
Q2 		– Sell
-1,000
Closed -$51K – 1106
2017
Q1 		$51K Sell
1,000
-200
-17% -$9.24K 0.01% 1009
2016
Q4 		$45K Buy
+1,200
New +$50.2K 0.01% 974
2016
Q2 		– Sell
-7,800
Closed -$490K – 1101
2016
Q1 		$490K Buy
+7,800
New +$519K 0.06% 471
2015
Q4 		– Sell
-7,100
Closed -$571K – 758
2015
Q3 		$571K Sell
7,100
-3,300
-32% -$367K 0.07% 346
2015
Q2 		$1.25M Buy
10,400
+3,500
+51% +$418K 0.17% 160
2015
Q1 		$720K Buy
+6,900
New +$699K 0.13% 208

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

NumerixS Investment Technologies's ALNY Position: Q4 2019 in Review

NumerixS Investment Technologies sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2019, closing a stake of 800 shares — an estimated $64K sold.

NumerixS Investment Technologies first reported a position in ALNY in Q1 2015 and held it in 10 quarters. The position peaked at $1.25M in Q2 2015. 316 funds tracked by Wall St. Rank hold ALNY as of Q4 2019.

  • NumerixS Investment Technologies reported no remaining Alnylam Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 800 Alnylam Pharmaceuticals shares in Q4 2019, an estimated $64K.
  • NumerixS Investment Technologies first reported a position in Alnylam Pharmaceuticals in Q1 2015 and held it in 10 quarters.
  • NumerixS Investment Technologies's Alnylam Pharmaceuticals position peaked at $1.25M in Q2 2015.
  • 316 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2019.

Based on NumerixS Investment Technologies's 13F filing for Q4 2019, filed 12 Feb 2020.